[DOI] [PMC free article] [PubMed] [Google Scholar] 12.Kupchik Y.M., Moussawi K., Tang X.-C., Wang X., Kalivas B.C., Kolokithas R., Ogburn K.B., Kalivas P.W
Cardiovasc Drugs Ther 27:371380 Rizzo M, Chandalia M, Patti AM, Di Bartolo V, Rizvi AA, Montalto G, Abate N (2014) Liraglutide decreases carotid intima-media thickness in patients with type 2 diabetes: 8-month prospective pilot study
Some of these cases were associated with external iatrogenic procedures, suggesting the role of trauma as an inducing factor (Figure 30)
The clinical development program for orforglipron is among the most extensive in the history of obesity pharmacotherapy
l , Weight curves of female Het and KO mice on a No Cys diet with either 0.4% NAC or 1% GSH in drinking water (n 4 per group)